Research shows that a combination of two beneficial bacteria—Lactobacillus acidophilus LA15 and Bifidobacterium animalis subsp. lactis Bi66—significantly reduced immune system damage in mice treated with cyclophosphamide chemotherapy. According to Gram Research analysis, the probiotics restored immune organ function, rebalanced protective immune chemicals, and repaired the gut lining by activating specific immune pathways and increasing protective compounds produced by healthy gut bacteria.
According to Gram Research analysis, a new study found that two specific types of beneficial bacteria—Lactobacillus acidophilus LA15 and Bifidobacterium animalis subsp. lactis Bi66—may help protect the immune system from damage caused by cyclophosphamide, a common chemotherapy drug. In mice treated with this chemotherapy, the probiotic combination restored immune function, repaired the gut lining, and increased protective compounds in the digestive system. The research suggests these probiotics work by rebalancing gut bacteria and activating specific immune pathways, offering hope for developing new supportive treatments alongside cancer therapy.
Key Statistics
A 2026 research article found that mice receiving a probiotic combination of Lactobacillus acidophilus LA15 and Bifidobacterium animalis subsp. lactis Bi66 showed dose-dependent restoration of immune organ size and function after cyclophosphamide chemotherapy treatment.
According to the 2026 study, probiotic-treated mice demonstrated significantly elevated fecal short-chain fatty acid concentrations and upregulated intestinal barrier genes compared to chemotherapy-only controls.
The research demonstrated that the probiotic combination activated aryl hydrocarbon receptor (AhR) signaling pathways while suppressing opportunistic pathogenic bacteria in the gut microbiota of chemotherapy-treated mice.
The Quick Take
- What they studied: Whether two specific probiotics could protect mice’s immune systems from damage caused by cyclophosphamide, a chemotherapy drug commonly used to treat cancer
- Who participated: Laboratory mice that received cyclophosphamide treatment, with some receiving the probiotic combination and others serving as controls
- Key finding: Mice given the probiotic combination showed significant recovery of immune function, including restored immune organ size, balanced immune chemicals, and repaired gut lining compared to untreated mice
- What it means for you: This research suggests probiotics might become a helpful addition to chemotherapy treatment to reduce immune damage, though human studies are still needed to confirm these results
The Research Details
Researchers gave mice a chemotherapy drug called cyclophosphamide, which damages the immune system and disrupts healthy gut bacteria. Some mice received the probiotic combination while others did not. Scientists then measured immune function, gut bacteria composition, intestinal health, and specific immune signaling pathways in both groups.
The study examined multiple markers of immune health, including the size of immune organs (thymus and spleen), levels of immune-signaling chemicals called cytokines, and the diversity of bacteria in the digestive system. Researchers also looked at short-chain fatty acids, which are protective compounds produced by healthy gut bacteria.
This approach allowed researchers to understand not just whether the probiotics worked, but also how they worked—through which biological pathways and mechanisms they provided protection.
Chemotherapy drugs like cyclophosphamide save lives but have a serious side effect: they severely weaken the immune system, making patients vulnerable to infections and potentially reducing the effectiveness of treatment. Finding safe, natural ways to protect immune function during chemotherapy could improve patient outcomes and quality of life. This study’s detailed examination of how probiotics work helps explain the biological mechanisms, making the findings more credible and useful for developing future treatments.
This is a controlled laboratory study in mice, which means it was carefully designed with comparison groups and measured multiple relevant outcomes. The researchers examined the biological mechanisms in detail, not just surface-level results. However, because this was conducted in mice rather than humans, results may not directly translate to people. The study was published in a peer-reviewed scientific journal, indicating it met professional standards for research quality.
What the Results Show
The probiotic combination significantly protected mice from chemotherapy-induced immune damage. Mice receiving the probiotics showed restored size of immune organs (thymus and spleen), which had shrunk from the chemotherapy. Their immune-signaling chemicals (cytokines) returned to more balanced levels, and their ability to fight infections improved.
The probiotics also repaired damage to the intestinal lining, which had been disrupted by the chemotherapy. This is important because a healthy gut barrier prevents harmful bacteria from entering the bloodstream. Additionally, the probiotics increased production of short-chain fatty acids—protective compounds that support immune function and gut health.
Microbial analysis showed that the probiotic treatment restored healthy bacterial diversity in the gut, reducing harmful bacteria while promoting beneficial species. The researchers also found that the probiotics activated specific immune signaling pathways (AhR/ERK/STAT3), which are important for maintaining immune balance and intestinal health.
The protective effects appeared to be dose-dependent, meaning higher doses of probiotics provided greater protection. The probiotics not only restored immune function but also prevented the overgrowth of opportunistic pathogens (harmful bacteria that take advantage of a weakened system). The intestinal tissue showed visible healing under microscopic examination, with restored structural integrity and reduced inflammation.
This research builds on growing evidence that gut bacteria play a crucial role in immune function and that probiotics may help during medical treatments. Previous studies suggested probiotics could support immunity, but this work provides detailed mechanistic evidence showing exactly how these specific strains protect against chemotherapy damage. The focus on the gut-immune axis and specific signaling pathways represents an advancement in understanding probiotic mechanisms.
This study was conducted in mice, not humans, so results may not directly apply to people. The sample size and specific mouse strains used were not detailed in the abstract. The research examined only one chemotherapy drug (cyclophosphamide) and one probiotic combination, so results may not generalize to other drugs or probiotic formulations. Long-term effects and optimal dosing for humans remain unknown. Human clinical trials would be necessary to confirm these findings and determine safe, effective doses for cancer patients.
The Bottom Line
Based on this research, the probiotic combination of Lactobacillus acidophilus LA15 and Bifidobacterium animalis subsp. lactis Bi66 shows promise as a potential supportive treatment during chemotherapy. However, confidence in human application is moderate because this is animal research. Anyone undergoing chemotherapy should discuss probiotic use with their oncologist before starting, as some probiotics may interact with treatment or be inappropriate for certain patients with compromised immune systems.
This research is most relevant to cancer patients undergoing chemotherapy with cyclophosphamide, their doctors, and researchers developing supportive care strategies. It may also interest people interested in gut health and immune function generally. However, people should not self-treat with these specific probiotics without medical guidance, as the research is preliminary and individual circumstances vary significantly.
In the mouse study, protective effects were observed during and after chemotherapy treatment. For humans, if these findings translate, benefits would likely develop over weeks of consistent probiotic use, though this timeline is speculative based on animal research. Actual human studies would be needed to establish realistic timeframes for immune recovery.
Frequently Asked Questions
Can probiotics help protect your immune system during chemotherapy?
Research in mice shows that specific probiotic strains (Lactobacillus acidophilus LA15 and Bifidobacterium animalis subsp. lactis Bi66) significantly reduced immune damage from chemotherapy by restoring immune function and repairing the gut lining. However, human studies are needed to confirm these results.
How do probiotics protect the immune system from chemotherapy damage?
The probiotics work by restoring healthy gut bacteria diversity, increasing protective compounds called short-chain fatty acids, repairing the intestinal barrier, and activating specific immune signaling pathways (AhR/ERK/STAT3) that support immune balance and function.
Are these probiotics safe to take during cancer treatment?
While this research is promising, patients should always consult their oncologist before starting any probiotic during chemotherapy, as some probiotics may be inappropriate for severely immunocompromised patients or could interact with specific treatments.
What are short-chain fatty acids and why do they matter for chemotherapy patients?
Short-chain fatty acids are protective compounds produced by healthy gut bacteria. They support immune function, strengthen the intestinal barrier, and reduce inflammation—all important for protecting patients undergoing chemotherapy from infection and complications.
When will these probiotics be available as a cancer treatment?
This mouse research is preliminary. Human clinical trials would be necessary before these specific probiotics could be recommended as standard supportive care for chemotherapy patients. Development and approval typically takes several years.
Want to Apply This Research?
- Track daily probiotic intake (if recommended by your doctor), infection symptoms or illness episodes, energy levels, and digestive health markers like bowel regularity and bloating on a weekly basis during chemotherapy treatment
- If your oncologist approves, establish a daily routine of taking the recommended probiotic dose at the same time each day, paired with a consistent meal to improve absorption and adherence
- Maintain a health journal documenting infection frequency, immune-related symptoms, and overall wellness during treatment. Share this data with your healthcare team to assess whether probiotics are providing noticeable benefits in your individual case
This research was conducted in mice and has not been tested in humans. These findings are preliminary and should not be used to self-treat or replace medical advice from your oncologist. Anyone undergoing chemotherapy should consult their healthcare team before starting any probiotic supplement, as some probiotics may be contraindicated in severely immunocompromised patients or may interact with cancer treatments. This article is for informational purposes only and does not constitute medical advice.
This research translation is published by Gram Research, the science division of Gram, an AI-powered nutrition tracking app.